MedTrace Logo

Prediction of PEP Based on the Appearance of the Major Duodenal Papilla

NCT05800626 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1740

Last updated 2024-02-28

No results posted yet for this study

Summary

This observational, prospective study aims at evaluating how the occurrence of post-Endoscopic Retrograde CholangioPancreatography (ERCP) acute pancreatitis (PEP) could be influenced by difficult biliary cannulation that might be previously assessed by the morphological appearance of native major papilla in all the patients undergoing ERCP.

The rate of successful biliary cannulation across papilla types could be used as intraprocedural quality and competence metrics during training. Moreover, recognizing difficult papillae could allow reserving those to experts to decrease the odds of failed cannulation.

Conditions

  • Post-ERCP Acute Pancreatitis

Interventions

PROCEDURE

Endoscopic Retrograde Cholangio-Pancreatography (ERCP)

ERCP performed for clinical practice

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-04-01
Completion
2025-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05800626 on ClinicalTrials.gov